marketcaparena
Search

    BBIO

    BridgeBio Pharma, Inc.

    Company overview

    Market capitalization
    $13.02B
    Employees
    834
    Latest publication
    2026-09-29
    About BridgeBio Pharma, Inc.

    BridgeBio Pharma, Inc., a biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases. The company offers Attruby, a next-generation oral small molecule near-complete TTR stabilizer for the treatment of cardiomyopathy of wild-type or transthyretin-mediated amyloidosis (ATTR-CM); Fosdenopterin, an intravenous formulation of synthetic cyclic pyranopterin monophosphate for the treatment of molybdenum cofactor deficiency under the NULIBRY brand name; and low-dose infigratinib, an oral FGFR1-3 selective tyrosine kinase inhibitor, which is in Phase 3 clinical stage or the treatment of children with achondroplasia and hypochondroplasia. It also develops Encaleret, an oral small molecule, negative allosteric modulator of the calcium sensing receptor, which is in phase 3 clinical study for the treatment of Autosomal Dominant Hypocalcemia Type 1(ADH1) and Chronic Hypoparathyroidism (CHP); BBP-418, an investigational, orally administered, and small molecule therapy that is in phase 3 clinical study for the treatment of LGMD2I; and BBP-812, an investigational adeno-associated virus (AAV) gene therapy for Canavan disease. In addition, the company engages in developing products for mendelian, oncology, and gene therapy diseases. It has license and collaboration agreements with the Bayer Consumer Care AG, Alexion Pharma International Operations Limited Company, Leland Stanford Junior University, and Novartis International Pharmaceutical Ltd. BridgeBio Pharma, Inc. was founded in 2015 and is headquartered in Palo Alto, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USDQ3 20232023-09-30 · USDQ4 20182018-12-31 · USDQ2 20182018-06-30 · USD
    Total Revenue243,676,000USD5,882,000USD2,732,000USD2,168,000USD211,120,000USD4,091,000USD——
    Cost Of Revenue15,046,000USD2,084,000USD598,000USD598,000USD598,000USD598,000USD——
    Gross Profit228,630,000USD3,798,000USD2,134,000USD1,570,000USD210,522,000USD3,493,000USD——
    Research Development149,448,000USD130,350,000USD120,444,000USD114,695,000USD140,972,000USD125,136,000USD51,202,000USD23,892,000USD
    Selling General Administrative186,261,000USD94,782,000USD68,819,000USD59,523,000USD65,807,000USD35,777,000USD14,381,000USD10,891,000USD
    Other Operating Expenses0USD———————
    Total Operating Expenses335,709,000USD229,825,000USD193,884,000USD177,109,000USD210,179,000USD161,185,000USD65,583,000USD34,783,000USD
    Operating Income-107,079,000USD-226,027,000USD-191,750,000USD-175,539,000USD343,000USD-157,692,000USD-65,583,000USD-34,783,000USD
    Total Other Income Expense Net-48,812,000USD-40,209,000USD27,496,000USD99,995,000USD-36,503,000USD-21,796,000USD16,342,000USD-919,000USD
    Interest Income6,659,000USD4,683,000USD3,296,000USD5,195,000USD4,075,000USD3,793,000USD——
    Interest Expense13,278,000USD29,821,000USD23,061,000USD22,937,000USD23,471,000USD20,306,000USD1,179,000USD205,000USD
    Income Before Tax-155,891,000USD-266,236,000USD-164,254,000USD-75,544,000USD-36,160,000USD-179,488,000USD-49,241,000USD-35,702,000USD
    Income Tax Expense0USD1,153,000USD—-2,088,000USD-944,000USD-1,639,000USD-9,691,000USD-9,662,000USD
    Equity Method Income Loss-6,435,000USD———————
    Net Income-155,891,000USD-265,050,000USD-162,040,000USD-73,456,000USD-35,216,000USD-176,999,000USD-38,641,000USD-26,551,000USD
    Minority Interest-3,675,000USD2,339,000USD2,214,000USD2,088,000USD944,000USD2,489,000USD—58,520,000USD
    Net Income Applicable To Common Shares-152,216,000USD——————-30,405,000USD
    Unclassified Operating Expenses—4,693,000USD4,621,000USD2,891,000USD3,400,000USD———
    Net Interest Income—-25,138,000USD-19,765,000USD-17,742,000USD-19,396,000USD-16,513,000USD——
    Net Income From Continuing Ops—-267,389,000USD-164,254,000USD-75,544,000USD-36,160,000USD-179,488,000USD—-35,702,000USD
    Ebit—-236,415,000USD-141,193,000USD-52,607,000USD-12,689,000USD-159,182,000USD-48,062,000USD-35,497,000USD
    Ebitda—-235,048,000USD-139,655,000USD-51,033,000USD-11,093,000USD-157,543,000USD-47,962,000USD-35,455,000USD
    Depreciation And Amortization—1,367,000USD1,538,000USD1,574,000USD1,596,000USD1,639,000USD100,000USD42,000USD
    Reconciled Depreciation—1,367,000USD1,538,000USD1,574,000USD1,596,000USD1,639,000USD100,000USD42,000USD
    Tax Provision———0USD————
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20192019-12-31 · USDFY 20172017-12-31 · USD
    Total Revenue40,560,000USD0USD
    Cost Of Revenue2,500,000USD260,000USD
    Gross Profit38,060,000USD-260,000USD
    Research Development209,947,000USD30,556,000USD
    Selling General Administrative94,353,000USD13,302,000USD
    Total Operating Expenses304,300,000USD43,858,000USD
    Operating Income-266,240,000USD-43,858,000USD
    Interest Income8,915,000USD39,000USD
    Interest Expense8,765,000USD13,000USD
    Net Interest Income150,000USD26,000USD
    Income Before Tax-288,585,000USD-43,832,000USD
    Income Tax Expense-28,148,000USD-13,488,000USD
    Net Income-260,437,000USD-30,565,000USD
    Net Income From Continuing Ops-288,585,000USD-43,832,000USD
    Ebit-279,820,000USD-43,819,000USD
    Ebitda-278,961,000USD-43,559,000USD
    Depreciation And Amortization859,000USD260,000USD
    Total Other Income Expense Net-22,345,000USD26,000USD
    Minority Interest67,522,000USD3,331,000USD
    Net Income Applicable To Common Shares-260,587,000USD-30,565,000USD
    Reconciled Depreciation—260,000USD
    SourceLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets1,217,299,000USD1,370,981,000USD936,025,000USD998,250,000USD1,080,190,000USD881,638,000USD919,338,000USD664,977,000USD
    Cash And Equivalents677,911,000USD———————
    Total Current Assets1,093,138,000USD1,178,392,000USD753,679,000USD839,382,000USD912,277,000USD695,173,000USD720,692,000USD444,578,000USD
    Other Current Assets65,652,000USD62,914,000USD44,070,000USD52,395,000USD59,791,000USD35,354,999USD34,869,000USD177,776,000USD
    Other Non Current Assets20,120,000USD———————
    Total Liabilities3,723,192,000USD———————
    Total Current Liabilities890,648,000USD816,372,000USD287,971,000USD216,600,000USD175,854,000USD152,105,000USD154,400,000USD139,216,000USD
    Other Current Liabilities192,186,000USD———————
    Other Non Current Liabilities240,000USD———————
    Total Stockholder Equity-2,515,215,000USD-2,268,875,000USD-2,076,581,000USD-1,933,070,000USD-1,787,860,000USD-1,648,395,000USD-1,467,904,000USD-1,229,922,000USD
    Total Equity Including Noncontrolling Interest-2,505,893,000USD———————
    Deferred Revenue5,546,000USD———————
    Deferred Revenue Non Current10,424,000USD———————
    Net Receivables254,484,000USD205,226,000USD139,444,000USD116,518,000USD76,868,000USD115,265,000USD4,722,000USD478,000USD
    Inventory52,842,000USD32,980,000USD26,753,000USD24,527,000USD18,277,000USD3,954,000USD0USD—
    Property Plant Equipment Net22,305,000USD22,167,000USD13,515,000USD12,383,000USD12,293,000USD13,864,000USD12,778,000USD15,140,000USD
    Intangible Assets26,641,000USD27,359,000USD28,077,000USD28,795,000USD29,513,000USD27,802,000USD23,926,000USD24,525,000USD
    Accounts Payable27,202,000USD29,058,000USD36,228,000USD18,702,000USD26,134,000USD27,525,000USD9,618,000USD13,363,000USD
    Short Term Debt3,315,000USD573,410,000USD17,413,000USD5,294,000USD14,376,000USD5,209,000USD4,506,000USD4,600,000USD
    Common Stock206,000USD204,000USD202,000USD200,000USD198,000USD197,000USD196,000USD195,000USD
    Retained Earnings-4,137,453,000USD-3,985,237,000USD-3,821,194,000USD-3,628,331,000USD-3,445,588,000USD-3,263,685,000USD-3,096,263,000USD-2,831,213,000USD
    Accumulated Other Comprehensive Income-7,000USD-8,000USD12,000USD2,000USD1,000USD0USD7,999USD5,000USD
    Total Liab—3,639,856,000USD3,012,606,000USD2,920,979,000USD2,858,609,000USD2,520,303,000USD2,376,950,000USD1,883,369,000USD
    Other Current Liab—196,013,000USD214,060,000USD183,517,000USD124,804,000USD119,371,000USD140,276,000USD109,482,000USD
    Capital Stock—204,000USD202,000USD200,000USD198,000USD197,000USD196,000USD195,000USD
    Other Assets—143,063,000USD140,754,000USD———196,811,000USD—
    Cash—879,891,000USD570,119,000USD642,951,000USD749,402,000USD540,599,000USD681,101,000USD266,324,000USD
    Cash And Short Term Investments—940,186,000USD587,482,000USD645,942,000USD757,341,000USD540,599,000USD681,101,000USD266,324,000USD
    Current Deferred Revenue—17,891,000USD20,270,000USD9,087,000USD10,540,000USD11,620,000USD14,604,000USD11,771,000USD
    Net Debt—2,504,998,000USD2,158,605,000USD1,216,786,000USD1,927,735,000USD1,317,649,000USD1,049,483,000USD1,463,425,000USD
    Short Long Term Debt—547,483,000USD——————
    Short Long Term Debt Total—3,384,889,000USD2,728,724,000USD1,859,737,000USD2,677,137,000USD1,858,248,000USD1,730,584,000USD1,729,749,000USD
    Long Term Debt—1,926,078,000USD1,852,470,000USD1,851,016,000USD1,849,559,000USD1,848,124,000USD1,721,382,000USD1,719,316,000USD
    Long Term Investments—61,529,000USD79,972,000USD92,168,000USD108,002,000USD128,191,000USD143,747,000USD160,443,000USD
    Short Term Investments—60,295,000USD17,363,000USD2,991,000USD7,939,000USD—0USD0USD
    Property Plant Equipment Gross—22,167,000USD13,515,000USD12,383,000USD12,293,000USD13,864,000USD12,778,000USD15,140,000USD
    Common Stock Shares Outstanding—194,789,897shares197,238,000shares190,517,215shares190,517,215shares190,145,000shares189,437,438shares188,510,000shares
    Non Current Assets Total—49,526,000USD41,592,000USD158,868,000USD167,913,000USD186,465,000USD198,646,000USD220,399,000USD
    Non Current Liabilities Total—2,823,484,000USD2,724,635,000USD2,704,379,000USD2,682,755,000USD2,368,198,000USD2,222,550,000USD1,744,153,000USD
    Non Current Liabilities Other—229,000USD244,000USD679,000USD545,000USD352,000USD286,000USD377,000USD
    Non Currrent Assets Other—-63,106,000USD-81,443,000USD25,522,000USD16,407,000USD16,608,000USD18,195,000USD20,291,000USD
    Net Working Capital—424,934,000USD509,778,000USD622,782,000USD736,423,000USD543,068,000USD566,292,000USD305,362,000USD
    Unclassified Current Assets—-62,914,000USD-44,070,000USD—————
    Unclassified Non Current Assets—-204,592,000USD-220,726,000USD—1,698,000USD—-196,811,000USD—
    Unclassified Current Liabilities—-547,483,000USD———-11,620,000USD-14,604,000USD—
    Unclassified Non Current Liabilities—897,177,000USD871,921,000USD852,684,000USD832,651,000USD519,722,000USD500,882,000USD24,460,000USD
    Unclassified Equity—1,715,962,000USD1,744,197,000USD1,694,859,000USD1,657,331,000USD1,614,896,000USD1,627,959,001USD1,600,896,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets936,025,000USD919,338,000USD546,380,000USD623,036,000USD1,012,792,000USD703,588,000USD631,679,000USD464,941,000USD
    Intangible Assets28,077,000USD23,926,000USD26,319,000USD28,712,000USD44,934,000USD———
    Other Current Assets44,070,000USD34,869,000USD40,958,000USD59,852,000USD32,446,000USD35,731,000USD19,784,000USD9,137,000USD
    Total Liab3,012,606,000USD2,376,950,000USD1,888,915,000USD1,867,960,000USD1,878,371,000USD595,702,000USD155,703,000USD566,444,000USD
    Total Stockholder Equity-2,076,581,000USD-1,467,904,000USD-1,354,257,000USD-1,254,617,000USD-870,414,000USD57,906,000USD408,454,000USD-163,986,000USD
    Other Current Liab214,060,000USD140,276,000USD122,965,000USD98,039,000USD118,247,000USD81,450,000USD51,533,000USD19,068,000USD
    Common Stock202,000USD196,000USD181,000USD157,000USD154,000USD125,000USD124,000USD6,594,000USD
    Capital Stock202,000USD196,000USD181,000USD157,000USD154,000USD125,000USD124,000USD6,594,000USD
    Retained Earnings-3,821,194,000USD-3,096,263,000USD-2,560,501,000USD-1,918,149,000USD-1,436,966,000USD-888,755,000USD-440,031,000USD-170,580,000USD
    Other Assets140,754,000USD—1USD140,808,000USD33,027,000USD23,931,000USD26,288,000USD1,093,000USD
    Cash570,119,000USD681,101,000USD375,935,000USD376,689,000USD393,772,000USD356,082,000USD363,773,000USD436,086,000USD
    Cash And Short Term Investments587,482,000USD681,101,000USD434,884,000USD471,922,000USD836,663,000USD607,093,000USD545,993,000USD436,086,000USD
    Total Current Assets753,679,000USD720,692,000USD477,593,000USD548,853,000USD888,858,000USD642,824,000USD568,622,000USD445,223,000USD
    Total Current Liabilities287,971,000USD154,400,000USD143,844,000USD121,428,000USD135,069,000USD95,648,000USD60,385,000USD32,577,000USD
    Current Deferred Revenue20,270,000USD14,604,000USD6,096,000USD8,156,000USD—75,900,000USD31,455,000USD—
    Net Debt2,158,605,000USD1,049,483,000USD1,363,903,000USD1,346,875,000USD1,332,399,000USD139,705,000USD-271,982,000USD-381,579,000USD
    Short Term Debt17,413,000USD4,506,000USD4,128,000USD3,675,000USD4,938,000USD5,253,000USD8,000,000USD—
    Short Long Term Debt Total2,728,724,000USD1,730,584,000USD1,739,838,000USD1,723,564,000USD1,726,171,000USD495,787,000USD91,791,000USD54,507,000USD
    Long Term Debt1,852,470,000USD1,721,382,000USD1,726,729,000USD1,707,615,000USD1,703,805,000USD475,857,000USD91,791,000USD54,507,000USD
    Long Term Investments79,972,000USD143,747,000USD0USD43,653,000USD49,148,000USD0USD31,144,000USD17,050,000USD
    Short Term Investments17,363,000USD0USD58,949,000USD95,233,000USD442,891,000USD251,011,000USD182,220,000USD—
    Net Receivables139,444,000USD4,722,000USD1,751,000USD17,079,000USD19,749,000USD—2,845,000USD—
    Inventory26,753,000USD0USD16,653,000USD37,930,000USD-68,897,000USD———
    Accounts Payable36,228,000USD9,618,000USD10,655,000USD11,558,000USD11,884,000USD8,945,000USD8,852,000USD13,509,000USD
    Property Plant Equipment Net13,515,000USD12,778,000USD19,843,000USD25,247,000USD45,973,000USD36,833,000USD5,625,000USD1,575,000USD
    Property Plant Equipment Gross13,515,000USD12,778,000USD19,843,000USD25,247,000USD45,973,000USD36,833,000USD5,625,000USD1,575,000USD
    Accumulated Other Comprehensive Income12,000USD7,999USD31,000USD-328,000USD-132,000USD191,999USD254,000USD-231,000USD
    Common Stock Shares Outstanding197,238,000shares186,076,000shares162,791,511shares147,473,076shares144,356,619shares117,995,457shares105,099,089shares92,330,072shares
    Non Current Assets Total41,592,000USD198,646,000USD68,786,999USD74,183,000USD123,934,000USD60,764,000USD63,057,000USD19,718,000USD
    Non Current Liabilities Total2,724,635,000USD2,222,550,000USD1,745,071,000USD1,746,532,000USD1,743,302,000USD500,054,000USD95,318,000USD533,867,000USD
    Non Current Liabilities Other244,000USD286,000USD9,361,000USD26,643,000USD39,497,000USD24,197,000USD3,527,000USD495,000USD
    Non Currrent Assets Other-81,443,000USD18,195,000USD18,880,999USD17,359,000USD30,611,000USD23,931,000USD26,288,000USD1,093,000USD
    Net Working Capital509,778,000USD566,292,000USD333,749,000USD387,447,000USD709,579,000USD547,176,000USD508,237,000USD412,646,000USD
    Unclassified Current Assets-44,070,000USD—-16,653,000USD-37,930,000USD————
    Unclassified Non Current Assets-220,726,000USD—3,743,999USD-181,596,000USD-79,759,000USD-23,931,000USD-26,288,000USD-1,093,000USD
    Unclassified Non Current Liabilities871,921,000USD500,882,000USD——-22,069,000USD-7,947,000USD-3,527,000USD478,370,000USD
    Unclassified Equity1,744,197,000USD1,627,959,001USD1,205,851,000USD938,546,000USD841,376,000USD1,021,219,001USD847,983,000USD-6,363,000USD
    Unclassified Current Liabilities—-14,604,000USD———-77,358,000USD-39,455,000USD—
    Other Liab———26,643,000USD22,069,000USD7,947,000USD3,527,000USD495,000USD
    Treasury Stock———-275,000,000USD-275,000,000USD-75,000,000USD——
    Net Tangible Assets———-1,284,918,000USD-915,348,000USD59,536,000USD408,454,000USD314,879,000USD
    Short Long Term Debt—————1,458,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation2,239,000USD
    Stock Based Compensation77,314,000USD
    Other Non Cash Items-1,502,000USD
    Change To Account Receivables-115,040,000USD
    Change To Inventory-28,166,000USD
    Change To Liabilities43,379,000USD
    Change In Working Capital-153,392,000USD
    Operating Cash Flow-268,380,000USD
    Capital Expenditures-512,000USD
    Net Investments-24,337,000USD
    Investing Cash Flow-24,849,000USD
    Common Stock Issuance5,466,000USD
    Net Common Stock Issuance-218,344,000USD
    Unclassified Financing Cash Flow614,003,000USD
    Financing Cash Flow401,125,000USD
    Change In Cash107,896,000USD
    End Cash Flow680,036,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USD
    Net Income-166,555,000USD-190,263,000USD-182,743,000USD-183,758,000USD-169,608,000USD-267,389,000USD-73,456,000USD-36,160,000USD
    Depreciation1,819,000USD1,452,000USD1,398,000USD1,317,000USD1,284,000USD1,367,000USD1,574,000USD1,596,000USD
    Stock Based Compensation33,242,000USD34,639,000USD35,262,000USD37,241,000USD25,882,000USD30,127,000USD21,454,000USD17,057,000USD
    Other Non Cash Items58,956,000USD48,141,000USD75,702,000USD45,097,000USD59,373,000USD27,624,000USD-121,307,000USD23,169,000USD
    Change To Account Receivables-65,782,000USD-22,926,000USD-39,650,000USD38,397,000USD-110,543,000USD-4,244,000USD234,834,000USD-233,743,000USD
    Change To Inventory-7,053,000USD-1,951,000USD-6,774,000USD-13,389,000USD-3,193,000USD—0USD—
    Change In Working Capital-124,741,000USD49,611,000USD-3,931,000USD19,422,000USD-116,166,000USD12,945,000USD246,438,000USD-225,199,000USD
    Total Cash From Operating Activities-197,279,000USD-56,420,000USD-109,574,000USD-80,681,000USD-199,235,000USD-195,326,000USD74,703,000USD-219,537,000USD
    Capital Expenditures-69,000USD-4,533,000USD-470,000USD-5,094,000USD-1,595,000USD-3,237,000USD-2,447,000USD-1,492,000USD
    Free Cash Flow-197,348,000USD-60,953,000USD-110,044,000USD-85,775,000USD-200,830,000USD-198,563,000USD72,256,000USD-221,029,000USD
    Investments-42,666,000USD-14,321,000USD4,464,000USD-13,002,000USD-1,595,000USD-3,237,000USD3,039,000USD22,753,000USD
    Total Cashflows From Investing Activities-42,735,000USD-13,754,000USD4,464,000USD-13,002,000USD-1,595,000USD-3,237,000USD3,039,000USD22,753,000USD
    Net Borrowings632,500,000USD0USD-300,000,000USD300,000,000USD116,000,000USD500,000,000USD——
    Total Cash From Financing Activities549,892,000USD-2,782,000USD-894,000USD302,041,000USD60,328,000USD473,931,000USD-5,729,000USD279,548,000USD
    Sale Purchase Of Stock-82,500,000USD-5,547,000USD3,771,000USD-1,995,000USD-50,052,000USD-1,404,000USD-1,743,000USD-2,936,000USD
    Change In Cash309,878,000USD-72,408,000USD-106,325,000USD208,358,000USD-140,502,000USD275,368,000USD72,014,000USD82,764,000USD
    Begin Period Cash Flow572,140,000USD643,077,000USD749,402,000USD542,742,000USD683,244,000USD407,876,000USD475,353,000USD394,732,000USD
    End Period Cash Flow882,018,000USD572,140,000USD643,077,000USD751,100,000USD542,742,000USD683,244,000USD547,367,000USD477,496,000USD
    Other Cashflows From Financing Activities-4,074,000USD-7,430,000USD-3,025,000USD4,036,000USD-5,620,000USD-24,665,000USD241,000USD-9,353,000USD
    Issuance Of Capital Stock—0USD0USD0USD0USD0USD-495,000USD315,254,000USD
    Unclassified Investing Cash Flow—5,100,000USD-1,832,000USD9,594,000USD3,190,000USD6,427,000USD4,840,000USD-23,393,000USD
    Unclassified Financing Cash Flow—10,195,000USD298,360,000USD———-4,227,000USD291,837,000USD
    Other Cashflows From Investing Activities——2,302,000USD-4,500,000USD-1,595,000USD-3,190,000USD-2,393,000USD24,885,000USD
    Unclassified Operating Cash Flow——-35,262,000USD—————
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20182018-12-31 · USD
    Net Income-724,931,000USD-543,347,000USD-643,202,000USD-484,652,000USD-586,454,000USD-505,488,000USD-169,451,000USD
    Depreciation5,967,000USD6,075,000USD6,494,000USD6,771,000USD5,843,000USD3,088,000USD245,000USD
    Stock Based Compensation133,024,000USD95,800,000USD115,016,000USD91,559,000USD99,505,000USD58,459,000USD6,067,000USD
    Other Non Cash Items191,094,000USD-111,296,000USD103,931,000USD-61,251,000USD18,498,000USD31,159,000USD18,895,000USD
    Change To Account Receivables-134,722,000USD-2,971,000USD15,328,000USD15,169,000USD-19,749,000USD2,845,000USD-2,845,000USD
    Change To Inventory-25,307,000USD0USD-15,328,000USD-15,169,000USD19,749,000USD-2,845,000USD—
    Change In Working Capital-51,064,000USD32,042,000USD5,057,000USD28,079,000USD-4,396,000USD14,934,000USD22,491,000USD
    Total Cash From Operating Activities-445,910,000USD-520,726,000USD-527,720,000USD-419,494,000USD-497,934,000USD-399,714,000USD-136,643,000USD
    Capital Expenditures-1,097,000USD-933,000USD-1,306,000USD-6,321,000USD-48,246,000USD-7,518,000USD-18,178,000USD
    Free Cash Flow-447,007,000USD-521,659,000USD-529,026,000USD-425,815,000USD-546,180,000USD-407,232,000USD-154,821,000USD
    Investments-17,197,000USD60,781,000USD54,033,000USD453,147,000USD-166,234,000USD-38,715,000USD-21,036,000USD
    Total Cashflows From Investing Activities-24,487,000USD60,781,000USD54,033,000USD453,147,000USD-200,826,000USD-52,993,000USD-21,036,000USD
    Net Borrowings116,000,000USD476,583,000USD0USD-20,486,000USD1,063,613,000USD536,961,000USD56,341,000USD
    Total Cash From Financing Activities359,293,000USD748,457,000USD451,535,000USD-13,134,000USD736,446,000USD447,189,000USD501,548,000USD
    Sale Purchase Of Stock-48,276,000USD-7,526,000USD-6,880,000USD-1,561,000USD-204,746,000USD-75,714,000USD430,974,000USD
    Issuance Of Capital Stock0USD314,741,000USD449,810,000USD4,852,000USD0USD0USD430,534,000USD
    Change In Cash-111,104,000USD288,512,000USD-22,152,000USD20,519,000USD37,686,000USD-5,518,000USD343,869,000USD
    Begin Period Cash Flow683,244,000USD394,732,000USD416,884,000USD396,365,000USD358,679,000USD364,197,000USD92,376,000USD
    End Period Cash Flow572,140,000USD683,244,000USD394,732,000USD416,884,000USD396,365,000USD358,679,000USD436,245,000USD
    Other Cashflows From Investing Activities-6,193,000USD-7,975,000USD-503,000USD118,500,000USD-21,346,000USD-21,094,000USD-2,858,000USD
    Other Cashflows From Financing Activities-12,076,000USD-35,341,000USD8,605,000USD4,061,000USD1,065,311,000USD-27,097,000USD349,634,000USD
    Unclassified Financing Cash Flow303,645,000USD314,741,000USD449,810,000USD4,852,000USD-1,183,911,000USD550,000,000USD-335,401,000USD
    Unclassified Investing Cash Flow—8,908,000USD1,809,000USD-112,179,000USD35,000,000USD14,334,000USD21,036,000USD
    Unclassified Operating Cash Flow——-115,016,000USD—-30,930,000USD—-14,890,000USD
    Change To Liabilities———9,818,000USD22,218,000USD16,189,000USD16,700,000USD
    Cash And Cash Equivalents Changes———20,519,000USD37,686,000USD-5,518,000USD—
    Dividends Paid————-3,821,000USD-536,961,000USD0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    Late-stage Development Pipeline Product Candidates

    Period endPeriodValueUnitSource
    2026-06-30instant418product candidatesDisclosure

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2025Quarterly · 2025-03-31ProductLicense And Service79,690,000USD0001743881-26-000019
    Q1 2025Quarterly · 2025-03-31ProductProduct36,739,000USD0001743881-26-000019
    Q1 2025Quarterly · 2025-03-31ProductRoyalty204,000USD0001743881-26-000019
    FY 2024Yearly · 2024-12-31ProductLicense And Service218,849,000USD0001743881-26-000009
    FY 2024Yearly · 2024-12-31ProductProduct2,900,000USD0001743881-26-000009
    FY 2024Yearly · 2024-12-31ProductRoyalty169,000USD0001743881-26-000009
    Q3 2024Quarterly · 2024-09-30ProductLicense And Service2,732,000USD0001743881-25-000012
    Q3 2024Quarterly · 2024-09-30ProductProduct0USD0001743881-25-000012
    Q3 2024Quarterly · 2024-09-30ProductRoyalty0USD0001743881-25-000012
    FY 2023Yearly · 2023-12-31ProductLicense And Service9,303,000USD0001743881-26-000009
    FY 2023Yearly · 2023-12-31ProductProduct0USD0001743881-26-000009
    FY 2023Yearly · 2023-12-31ProductRoyalty0USD0001743881-26-000009
    Q1 2023Quarterly · 2023-03-31ProductLicense0USD0000950170-23-017812
    Q1 2023Quarterly · 2023-03-31ProductLicense And Service1,826,000USD0000950170-23-017812
    FY 2022Yearly · 2022-12-31ProductLicense0USD0000950170-23-004145
    FY 2022Yearly · 2022-12-31ProductLicense And Service76,094,000USD0000950170-23-004145
    FY 2022Yearly · 2022-12-31ProductProduct1,554,000USD0000950170-23-004145
    Q2 2022Quarterly · 2022-06-30ProductLicense0USD0000950170-22-014824
    Q2 2022Quarterly · 2022-06-30ProductLicense And Service73,746,000USD0000950170-22-014824
    Q1 2022Quarterly · 2022-03-31ProductLicense0USD0000950170-23-017812
    Q1 2022Quarterly · 2022-03-31ProductLicense And Service235,000USD0000950170-23-017812
    Q1 2022Quarterly · 2022-03-31ProductProduct1,459,000USD0000950170-23-017812
    FY 2021Yearly · 2021-12-31ProductLicense65,923,000USD0000950170-22-002030
    FY 2021Yearly · 2021-12-31ProductProduct3,793,000USD0000950170-22-002030
    Q3 2021Quarterly · 2021-09-30ProductLicense1,585,000USD0000950170-21-003080
    Q3 2021Quarterly · 2021-09-30ProductProduct759,000USD0000950170-21-003080
    Q2 2021Quarterly · 2021-06-30ProductLicense53,037,000USD0001564590-21-041676
    Q2 2021Quarterly · 2021-06-30ProductProduct987,000USD0001564590-21-041676
    FY 2020Yearly · 2020-12-31ProductLicense And Service8,249,000USD0000950170-23-004145
    FY 2020Yearly · 2020-12-31ProductProduct0USD0000950170-23-004145
    Q3 2020Quarterly · 2020-09-30ProductLicense8,127,000USD0000950170-21-003080
    Q3 2020Quarterly · 2020-09-30ProductProduct0USD0000950170-21-003080

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.